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ABSTRACT
Gene expression analysis using microarrays of
synthetic long oligonucleotides is limited in that it
requires substantial amounts of RNA. To obtain
these quantities from minute amounts of starting
material, protocols were developed that linearly amp-
lify mRNA by cDNA synthesis and in vitro transcrip-
tion. Since orientation of the product is antisense
(aRNA), it is inapplicable for dye-labelling by reverse
transcription and hybridization to sense-oriented
oligonucleotide arrays. Here, we introduce a novel
protocol in which aRNA labelling is achieved by a
combination of two reverse and one forward tran-
scription reactions followed by dye-incorporation
using Klenow fragment, generating fluorescent anti-
sense cDNA. We demonstrate high fidelity in arrays
using up to 10
5-fold amplification, starting from 2 ng
total RNA. The generated data are highly reproduc-
ible and maintain relative gene expression levels
between samples. These results demonstrate that
our protocol describes an efficient and reliable tech-
nique to expand the applicability of oligonucleotide
arrays to studies where RNA is the limited source
material.
INTRODUCTION
A restricting aspect of any array-based expression proﬁling
approach is the amount of RNA material needed for hybrid-
ization. cDNA arrays usually require at least 15 mg total RNA,
and the preferred amount for spotted oligonucleotide arrays is
increased to  50 mg, due to the decrease in possible base
pairings. Hence, reliable transcriptome ampliﬁcation is essen-
tial for many quantitative analytical approaches, such as RNA
expression analysis of tumour biopsies (1), sorted cell popu-
lations (2), laser capture microdissected cells and tissues (3) or
any other study based on small tissue samples or minute num-
bers of cells. Methods were developed that amplify initial
poly(A) RNA and, thereby, increase detection sensitivity by
orders of magnitude.
In principle, ampliﬁcation can either be performed expo-
nentially using PCR-based approaches (4–6), or in a linear
fashion, mostly by the generation of cDNA followed by in
vitro transcription with T7 RNA polymerase (7–10). However,
the kinetics of PCR-based methods implies that both
sequence-dependent and copy-number dependent bias will
be ampliﬁed exponentially as well and accumulate. Another
important issue is the inﬂuence of sampling errors when hand-
ling very limited amounts of RNA (11,12). For these reasons,
exponential ampliﬁcation protocols are generally considered
less applicative for quantitative transcriptome analyses.
T7-based methods, on the other hand, are routinely used for
the expression proﬁling studies in combination with cDNA
microarrays, and several studies have demonstrated their
reliability (9,10). Recently, large collections of long oligonuc-
leotides (50–80 bases) have become increasingly popular as
probes for spotted DNA arrays. Technical advantages of oli-
gonucleotide arrays include a constant DNA concentration
across all spots and biophysically optimized sequences, redu-
cing secondary structures, avoiding repetitive sequences and
providing a ﬁxed range for both Tm and length. This accounts
for more uniform, stable and predictable hybridization con-
ditions. However, starting from cellular, sense-oriented
mRNA, the orientation of T7-ampliﬁed RNA will be antisense
(aRNA). Therefore, it cannot be used for reverse transcription
labelling and hybridization to sense-oriented, gene-speciﬁc
oligonucleotide libraries. Oligonucleotides of commercial
libraries are sense-oriented to complement antisense targets
produced by reverse transcription of unampliﬁed RNA.
Sense cDNA derived from aRNA is incompatible for
hybridization to these sequences. Some approaches try to
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doi:10.1093/nar/gni029overcome this problem by producing labelled aRNA during in
vitro transcription (13), but in our hands the yield of this
procedure was insufﬁcient.
We developed and evaluated a new protocol that generates
labelled antisense cDNA, termed Target Ampliﬁcation and
cDNA Klenow Labelling for Expression analysis (TAcKLE).
TAcKLE utilizes mRNA ampliﬁcation by in vitro transcrip-
tion of cDNA, as ﬁrst described by van Gelder et al. (7), and
ﬂuorescent labelling by Klenow fragment. Initial mRNA
is copied by a RNase H
  Moloney murine leukaemia virus
reversetranscriptase(MMLVRT),usingamodiﬁedoligo(dT)-
primer toincorporate the promotersequence of phage T7 RNA
polymerase. RNase H treatment of the resulting heteroduplex
creates RNA fragments that prime second-strand synthesis by
Escherichia coli DNA polymerase I. Repeated transcription
from the T7 promoter on the cDNA template results in
multiple copies of aRNA, which may be reampliﬁed as
described previously (8). Finally, aRNA is reverse transcribed
into sense cDNA and used as template for Klenow
labelling, yielding mainly ﬂuorescent antisense cDNA as a
suitable target for oligonucleotide libraries in sense orientation
(Figure 1).
MATERIALS AND METHODS
RNA
High quality total RNA was purchased from Stratagene
(Amsterdam, The Netherlands). Universal Human Reference
RNA precipitate in ethanol was pelleted, washed in 70% (v/v)
ethanol, air dried and dissolved in RNase-free water at 5 mg/ml,
500 ng/ml, 50 ng/ml, 5 ng/ml and 0.5 ng/ml. Human Adult
Breast RNA was precipitated at  80 C for 30 min with
5 mg linear polyacrylamide (Ambion, Huntingdon, UK),
2.5 vol 100% (v/v) ethanol and 0.5 vol 7.5 M NH4OAc and
subsequently processed as described for the Reference
RNA. Integrity and purity of total RNA were assessed on a
Bioanalyzer 2100 (Agilent Technologies, Boeblingen,
Figure 1. Schematic overview of the TAcKLE protocol. mRNA is linearly amplified by in vitro transcription (‘T7 amplification’). The resulting aRNA is
subsequently converted to cDNA and labelled by dye-dUTP incorporation using Klenow fragment.
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according to the manufacturer’s instructions.
Target preparation
Preparation of labelled target cDNA for microarray hybrid-
izations was performed according to either of the methods
described below.
RT labelling. For the preparation of unampliﬁed cDNA target,
40 mg of total RNA were heated for 4 min at 70 C in the
presence of 2 mg oligo(dT21)VN in a total volume of 13.9 ml
and chilled on ice. Labelling mixture was added, yielding
ﬁnal concentrations of 1· First-Strand Buffer (Invitrogen,
Karlsruhe, Germany), 10 mM DTT (Invitrogen), 500 mM
each of dATP, dGTP and dCTP, 200 mM dTTP (Amersham
Biosciences, Freiburg, Germany), 100 mM Cy3- or Cy5-dUTP
(Amersham Biosciences), 2 U/ml RNasin ribonuclease inhib-
itor (Promega, Mannheim, Germany) as well as 13.33 U/ml
Superscript II reverse transcriptase (Invitrogen) in a total
volume of 30 ml. Samples were incubated ﬁrst at 25 C
for 3 min and, thereafter, at 42 C for 2 h, with further
200 U Superscript II (200 U/ml) added after 1 h. Next, 15 ml
0.1 M NaOH, containing 2 mM EDTA, were added to stop
the reaction. RNA was hydrolysed at 70 C for 20 min.
Finally, the pH was neutralized by the addition of 15 ml
0.1 M HCl.
TAcKLE. For ampliﬁcation and labelling using the TAcKLE
protocol, 2000, 200, 20 or 2 ng total RNA were employed
in the ﬁrst- and second-strand cDNA synthesis as described
previously (9), with minor modiﬁcations. Brieﬂy, RNA was
mixed with 100 ng (dT)-T7 primer [50-GCATTAGCGGCCG-
CGAAATTAATACGACTCACTATAGGGAGA(T)21VN-30]
to a ﬁnal volume of 5 ml, denatured 4 min at 70 C and chilled
on ice. Aliquots containing 5 ml ice-cold RT mixture were
added to the samples, yielding ﬁnal concentrations of 1·
First-Strand Buffer (Invitrogen), 10 mM DTT (Invitrogen),
500 mM of each dNTP (Amersham Biosciences), 400 ng/ml
T4gp32 (USB, Cleveland), 2 U/ml RNasin ribonuclease inhib-
itor (Promega) as well as 10 U/ml Superscript II reverse tran-
scriptase (Invitrogen). Reverse transcription was performed
for 1 h at 50 C and reactions were stopped by heating to
65 C for 15 min. Following the addition of 65 ml ice-cold
reaction mixture, second-strand synthesis was performed for
2ha t1 5  Ci n1 · Second-Strand buffer (Invitrogen), 200 mM
of each dNTP (Amersham Biosciences), 0.27 U/ml DNA poly-
merase I (Promega), 1 U RNase H (Epicentre, Madison) and
5UE.coli DNA ligase (USB). Then, 10 U T4 DNA poly-
merase (3.33 U/ml; New England Biolabs, Frankfurt a.M.,
Germany) were added to the samples, and cDNA ends were
polishedfor15min at15 C.Enzymeswere heat inactivated by
10 min incubation at 70 C. To extract double-stranded cDNA,
samples were mixed with 75 ml phenol/chloroform/isoamyl-
alcohol (pH 8.0; Sigma–Aldrich, Munich, Germany) and
transferred to prespun 0.5 ml PLG heavy tubes (Eppendorf,
Hamburg, Germany). After 5 min centrifugation at 13 000
r.p.m., the aqueous phase was further puriﬁed on a P-6
Micro BioSpin column (Bio-Rad, Munich, Germany) accord-
ing to the manufacturer’s instructions, followed by ethanol
precipitation. The cDNA was dissolved in 10 ml nuclease-
free water and employed in an in vitro transcription reaction
using a RiboMAX Large Scale RNA Production System T7
(Promega) according to the manufacturer’s recommendations,
but in 40 ml reaction volume and regularly mixing the samples
every 30 min for 6 h. Following puriﬁcation on RNeasy Mini
ﬁlters (Qiagen, Hilden, Germany) and ethanol precipitation,
aRNA was dissolved in nuclease-free water, preferentially at
0.25 mg/ml.
Second round RT was performed on 1 mg aRNA (where
available) as described above, but with the following modi-
ﬁcations: 0.5 mg random hexamer primer (Roche Diagnostics,
Mannheim, Germany) was used instead of (dT)-T7 primer.
Samples were incubated 5 min at room temperature before
the addition of RT mixture to allow for annealing of N6-
primer. The following temperature proﬁle was employed
for reverse transcription: 20 min at 37 C, 20 min at 42 C,
10 min at 50 C, 10 min at 55 C and 15 min at 65 C.
RNase H digestion (1 U per reaction) was carried out for
30 min at 37 C, followed by 2 min at 95 C to degrade
enzymes.
When starting with 20 ng total RNA or less, two rounds of
ampliﬁcation were performed. For this purpose, puriﬁed
aRNA samples were precipitated, dissolved in 4 ml
nuclease-free water and subjected to second round reverse
transcription as described above. First-strand cDNA was
mixed with 100 ng (dT)-T7 primer in a ﬁnal volume of
11 ml, incubated 10 min at 42 C and chilled on ice. Thereafter,
second-strand synthesis, cDNA puriﬁcation, in vitro transcrip-
tion, aRNA clean-up and third round reverse transcription
(primed with random hexamers) were performed as described
above.
cDNA labelling by Klenow fragment was performed using
the Bioprime Kit (Invitrogen), but with a modiﬁed protocol.
Brieﬂy, 10 ml cDNA sample were mixed with 90 ml Klenow
mixture to yield a reaction mixture that contained 1· random
primer solution (Invitrogen),200 mM each of dATP, dCTP and
dGTP, 50 mM dTTP (Amersham Biosciences), 30 mM Cy3- or
Cy5-dUTP (Amersham Biosciences) and 1.0 U/ml Klenow
fragment (Invitrogen). DNA polymerization was carried out
at 37 C for 16 h.
Preparation and post-processing of microarrays
Synthetic 70mer oligonucleotides (‘Human Genome Oligo Set
Version 2.1’; consisting of 21329 oligonucleotides represent-
ing human genes and transcripts plus 24 controls, as well as
‘Human Genome Oligo Set Version 2.1 Upgrade’, consisting
of 5462 human 70mer probes) were purchased from Operon
Technologies (Cologne, Germany) and dissolved in FBNC
spotting buffer (14) (formamide, betaine and nitrocellulose)
at 40 mM, using a MiniTrak robotic liquid handling system
(PerkinElmer, Rodgau-Juegesheim, Germany). DNA spotting
was performed in duplicates on QMT epoxysilane coated
slides (Quantifoil Micro Tools, Jena, Germany) using an
OmniGrid Microarrayer (GeneMachines, San Carlos)
equipped with Stealth SMP3 Micro Spotting Pins (Telechem,
Sunnyvale). Spot centres were 129 mm apart. DNA adhesion to
the glass surface was accomplished by 1 h incubation at 60 C,
followed by ultraviolet (UV) irradiation (2 · 120 mJ/cm
2
at 254 nm) in a Stratalinker Model 2400 UV illuminator
(Stratagene). Just prior to hybridization, slides were washed
for 2 min in 0.2% SDS (w/v), 2 min in ddH2O at room
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3 min centrifugation at 2000 r.p.m.
Microarray hybridization
Following completion of the labelling reactions, correspond-
ing cDNA samples were combined and puriﬁed on Microcon
YM-30 ﬁlter columns (Millipore, Eschborn, Germany), as
described previously (15). For blocking of repetitive sequence
elements, 25 mgC 0t-1 DNA (Roche Diagnostics), 25 mg
poly(A) RNA (Sigma) and 75 mg yeast tRNA (Sigma) were
added before the ﬁnal washing step. Puriﬁed, dye-labelled
cDNA was mixed with 120 ml UltraHyb hybridization buffer
(Ambion), agitated for 30–60 min at 60 C, then for 10 min
at 70 C on a thermo mixer and subsequently applied to
pre-heated (60 C) microarrays mounted in a GeneTAC
Hybridization Station (Genomic Solutions, Ann Arbor).
Hybridizations were performed for 16 h at 42 C with gentle
agitation. Thereafter, the arrays were automatically washed at
36 C with (i) 0.5· SSC, 0.1% (w/v) SDS for 5 min; (ii) 0.05·
SSC, 0.1% (w/v) SDS for 3 min; and (iii) 0.05· SSC for 2 min.
Flow time was set to 40 s. Immediately after the completion of
the ﬁnal washing step, the arrays were unmounted, immersed
in 0.05· SSC, 0.1% (w/v) Tween 20 and dried by centrifuga-
tion in 50 ml Falcon tubes (30 s at 500, 1000 and 1500 r.p.m.,
respectively, followed by a ﬁnal step of 90 s at 2000 r.p.m.).
Data acquisition, processing and analysis
Hybridized microarrays were scanned at 5 mm resolution
and variable PMT voltage to obtain maximal signal intensities
with <0.1% probe saturation, a count ratio of 0.8–1.2 (Cy5/
Cy3) and maximal congruence of histogram curves, using
a GenePix 4000B microarray scanner (Axon Instruments,
Union City). Subsequent image analysis was performed
with the corresponding software GenePix Pro 5.0. Spots not
recognized by the software were excluded from further con-
siderations. Result ﬁles containing all relevant scan data were
further processed using the statistical programming language
R (http://www.r-project.org) (16) together with packages of
the Bioconductor project (http://www.bioconductor.org) (16).
For each hybridization, raw ﬂuorescence intensities were nor-
malized applying variance stabilization (17). To eliminate low
quality data, the data points were ranked according to spot
homogeneity, as assayed by the ratio of median to mean ﬂuor-
escence intensity, the ratio of spot to local background intens-
ity and the standard deviation of the logarithmic ratios (log2
Cy5/Cy3) between spot replicates. Those data points ranked
among the lower 20% were removed from the data set. Genes
that could not be quantiﬁed in more than 33% of all experi-
ments after ﬁltering were excluded as well. To combine the
data of dye swap experiments, the log2-transformed intensity
ratios of one array were inverted and averaged with the cor-
responding values of the other array. To investigate the linear
relationship between data points in Figures 2–4, regression
lines were determined by minimizing the sum of squares of
the Euclidean distance of points to the ﬁtted line (‘orthogonal
regression’), as there is no clear assignment of dependent and
independent variables. Correlations were estimated using the
Pearson correlation coefﬁcient together with its 95% conﬁd-
ence interval. To compare log2 ratios obtained by TAcKLE
ampliﬁcations of 2000, 200, 20 and 2 ng starting material with
those obtained by RT labelling, a linear model with RT
labelling as reference was ﬁtted separately for each gene.
P-values were calculated using Wald statistics. This analysis
was performed for all spots with quantiﬁed log2 ratios in at
least 9 of the 10 arrays remaining after the exclusion of self–
self and dye swap hybridizations (see Table 1); hence,
the Wald statistics were checked for signiﬁcance using a
t-distribution with 4 or 5 degrees of freedom, respectively.
An optional ﬁltering procedure additionally excluded those
data points considered unreliable (18,19) as they correspond
to probe sets associated with low signal intensities less than
two standard deviations above local background. The magni-
tude of the effects and the corresponding P-values are illus-
trated as volcano plots (20).
Accession numbers
All relevant data from this study are available from GEO
(http://www.ncbi.nlm.nih.gov/geo) under the accession
numbers GPL1384 (for the array platform), GSM27816–
GSM27819, GSM27835, GSM27836 and GSM27915–
GSM27928 (for expression data from individual arrays) as
well as GSE1645 (for the experimental series).
RESULTS
Experimental design
A single source of reference (pooled from 10 human cell lines
representing distinct tissues) and breast total RNA was used
for all experiments to avoid variations in transcript abundance
imposed by the RNA preparation. Each RNA pool was serially
diluted to provide four distinct starting quantities equivalent to
2, 20, 200 and 2000 ng. In total, 20 two-colour hybridizations
were performed, comprising 1 co-hybridization of reference
RNA, 2 hybridizations of breast RNA versus reference RNA
(Cy5/Cy3) and 1 hybridization of reference RNA versus breast
RNA (dye swap), both for TAcKLE ampliﬁcations of all four
amounts of input material and for reverse transcription label-
ling (Table 1). All dye-labelling reactions using Klenow frag-
ment were made from separately ampliﬁed RNA aliquots. One
round of linear RNA ampliﬁcation resulted in  10
3-fold amp-
liﬁcation of starting mRNA, and two rounds yielded 10
5-fold
the starting amount. Labelled cDNAs were hybridized to
microarrays containing 26791 gene-speciﬁc 70mer oligonuc-
leotide probes, each spotted in duplicate.
Reproducibility of amplification
A ﬁrst assessment of random bias introduced by the ampli-
ﬁcation and labelling procedure was made by hybridizations
of differentially labelled targets, independently prepared from
the same dilutions of reference RNA. The Pearson correlation
coefﬁcient of ﬂuorescence intensities (Figure 2) was high for
all tested amounts of input RNA (r = 0.9945, r = 0.9900,
r = 0.9905 and r = 0.9657 for 2000, 200, 20 and 2 ng starting
material, respectively) and in good agreement with previously
reported values for T7-based ampliﬁcation protocols (9,10).
This reﬂects a reliable ampliﬁcation and consistent labelling
with both Cy5- and Cy3-dUTPs. There is an increased scat-
tering of low intensity data points for 2 ng of starting material,
which might be attributed to sampling errors (11,12) (i.e.
e29 Nucleic Acids Research, 2005, Vol. 33, No. 3 PAGE 4 OF 12errors resulting from the stochastic distribution of low-copy-
number templates) and represents a restricting aspect when
depending on very strong ampliﬁcations. Yet, the reproducib-
ility of the ampliﬁcation is equivalent or even superior when
compared with target preparation by reverse transcription
(r = 0.989; data not shown).
Reproducibility of expression ratios with and
without dye swap
To determine the effect of our ampliﬁcation procedure on the
reproducibility of expression ratios, we compared hybridiza-
tions of targets derived from human reference RNA and RNA
extracted from normal human breast tissue. The Pearson cor-
relations of log2-transformed normalized expression ratios
were r = 0.9948, r = 0.9889, r = 0.9780 and r = 0.9938 for
identically repeated hybridizations as well as r =  0.9803,
r =  0.9496, r =  0.9424 and r =  0.9017 for hybridizations
repeated with inverse assignment of ﬂuorophores (dye swap),
starting from 2000, 200, 20 and 2 ng RNA material, respect-
ively (Figure 3). Apparently, the concordance of expression
ratios is stable and independent of the amount of input RNA
for identically repeated experiments, but decreases consider-
ably in the case of dye swap repeats as the amount of starting
material is reduced. This might reﬂect differences in dye
incorporation between Cy3- and Cy-5 labelled dUTP, a
Figure 2. Scatterplotsoffluorescenceintensitiesfromreplicateamplificationandlabellingreactions.Co-hybridizationsofindependentlyamplifiedreferenceRNA
wereusedtoassessthereproducibilityofamplificationunderdiverseconditions.(A)2000ng;(B)200ng;(C)20ng;(D)2ngstartingmaterial.Orthogonalregression
lines are shown in red; the corresponding linear equations are given together with Pearson correlation coefficients and their 95% confidence intervals. A defined
section of the respective microarray image is displayed in the lower right corner of each plot.
Table 1. Experimental design (n denotes the number of arrays)
Group Labelling
method
Input/
channel
Breast versus
Ref. (n)
Ref. versus
Breast (n)
Ref. versus
Ref. (n)
1 TAcKLE 2 ng 2 1 1
2 TAcKLE 20 ng 2 1 1
3 TAcKLE 200 ng 2 1 1
4 TAcKLE 2000 ng 2 1 1
5R T 4 0 mg2 1 1
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pared by reverse transcription labelling (21). The respective
correlations for these unampliﬁed targets were r = 0.983 and
r =  0.873.
Comparison of amplified and unamplified targets
The main practical application of microarray analysis is
the identiﬁcation of transcripts whose abundance differs
between samples. To test the ﬁdelity of target ampliﬁcation,
we determined the ratios of ampliﬁed breast cDNA versus
ampliﬁed universal reference cDNA hybridizations, and
examined how these correlated with the corresponding ratios
obtained with unampliﬁed targets. This analysis was used to
test whether ampliﬁed targets would identify the same set of
differentially expressed transcripts recognizable with unamp-
liﬁed targets. Not unexpectedly, Pearson correlations of the
corresponding log2 ratios (r = 0.8727, r = 0.8713, r = 0.8565
and r = 0.8441 for the comparison of RT labelling with amp-
liﬁcations of 2000, 200, 20 and 2 ng starting material) were
not as high as for the comparison of repeated experiments
(Figure 4). The scattering of corresponding values increases
towards higher absolute log2 ratios. Additionally, we observed
an increase in the slope of the regression lines (m = 1.325,
m = 1.338, m = 1.355 and m = 1.379; same order as above),
demonstrating a common deviance in the absolute log2 ratios.
On average, absolute ratios obtained with ampliﬁed targets
were higher than those corresponding to the unampliﬁed
samples, prepared by reverse transcription labelling.
Linear modelling and statistical analysis
To determine whether the target ampliﬁcation affected our
ability to reliably proﬁle gene transcription in the breast tissue,
we analysed the relationship of the observed differences of
log2 ratios between ampliﬁed versus unampliﬁed targets and
the degree of differential expression. We found 1479, 1483,
1444 and 1667 genes to be up-regulated, and 1237, 1291, 1376
and 1598 genes to be down-regulated in samples TAcKLE-
ampliﬁed from 2000, 200, 20 and 2 ng RNA of healthy human
breast tissue when compared with universal human reference
RNA. A total of 1171 and 993 genes were identiﬁed as up- or
down-regulated by reverse transcription labelling, respect-
ively. Apparently, and in agreement with previous reports,
target ampliﬁcation yielded a slightly larger number of differ-
entiallyexpressedgenes(22,23).Thedistributionoflog2ratios
for the genes detected as differentially expressed in ampliﬁed
and/or unampliﬁed targets is depicted in Figure 5, which
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merely one method were close to reaching the threshold for
differential expression (2-fold difference) with the other
method as well. This observation is strengthened in
Figure 6, where of the genes common to the data sets
under comparison, only very few displayed a deviation of
log2 ratios >1o r< 1 (44 and 47, 72 and 57, 45 and 66,
and 85 and 115 genes, respectively, for the comparison of
dye-labelling by reverse transcription with TAcKLE ampli-
ﬁcations using 2000, 200, 20 and 2 ng starting material).
Additionally, we applied a linear model to assign P-values
to these differences. The results are displayed as volcano
plots (20,24) of P-value against log2 ratio difference (Figure
7). Supporting the ﬁndings of Figure 6, similarly small num-
bers ofgenes (26and33,59and43, 34and52,and 68and100)
showed a signiﬁcant (P < 0.001) difference of log2-trans-
formed ratios when comparing across the target preparation
techniques. In Figure 6, the intersection of the ‘outliers’ from
all amounts of starting material contains 275 genes for the
unﬁltered data sets and is empty for the ﬁltered data sets.
For Figure 7, the respective numbers of genes are 246 for
the unﬁltered data sets and 18 for the ﬁltered data sets. No
more than 1–4% of the considered probes were affected by
a >2-fold difference. Accordingly, there is strong concord-
ance between expression ratios obtained with ampliﬁed and
unampliﬁed targets.
DISCUSSION
RNA ampliﬁcation by in vitro transcription has been applied
for microarray studies of differential gene expression for
several years. This technique yields up to 10
5-fold linear
ampliﬁcation of high quality aRNA starting from nanogram
Figure 3. Scatter plots of log2-transformed expressionratios (log2 Cy5/Cy3) from duplicatehybridizations. Amplified breast and reference RNA, with and without
reversed assignment of fluorophores (dye swap) was employed to evaluate the accuracy and reproducibility of the experiment. Replicate spots were averaged.
(A) 2000 ng; (B) 2000 ng, dye swap; (C) 200 ng; (D) 200 ng, dye swap; (E) 20 ng; (F) 20 ng, dye swap; (G) 2 ng; (H) 2 ng, dye swap. The data were subjected to
orthogonalregressionanalysis(redlines),andassociatedlinearequationsarelistedalongwithPearsoncorrelationcoefficients.The95%confidenceintervalsofthe
correlation coefficients are (0.9946,0.9950), ( 0.9809,  0.9796), (0.9885, 0.9892), ( 0.9513,  0.9478),(0.9772, 0.9788), ( 0.9444,  0.9404), (0.9936, 0.9940)
and ( 0.9050,  0.8983) for (A) through (H). Underlying microarray images are shown as fixed sections in an upper (ordinate) and lower (abscissa) corner of
each plot.
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protocol broadens the utilityof this approach to the application
with spotted oligonucleotide microarrays and, thus, expands
the utilization of these microarrays to the analysis of rare cell
populations. These could be derived by ﬁne-needle aspiration
or microdissection of clinical specimens, by cell sorting or
micromanipulation of single cells. Utilizing elements of
the approved Eberwine procedure (7,8), the TAcKLE protocol
can easily be implemented, and even aRNA, produced
for other applications, can be made accessible for oligonuc-
leotide arrays by adding another reverse transcription and
labelling step.
The ampliﬁcation itself does not increase the overall vari-
ability above that encountered during cDNA synthesis. This
is clearly demonstrated by the co-hybridization of material
independently ampliﬁed from the same source. The reprodu-
cibility of a single round and even two rounds of ampliﬁcation,
estimated by the correlation coefﬁcient, is comparable or even
superior with that obtained with unampliﬁed targets and
possibly more biased by the variability of the chip hybridiza-
tion and readout procedure than by the enzymatic mani-
pulations.
The strong strand displacement activity of Klenow frag-
ment, combined with random priming of DNA polymeriza-
tion, adds a further level of ampliﬁcation (25,26) and, thereby,
decreases the amount of RNA necessary for labelling, facil-
itating the conduction of additional experiments even with
marginal amounts of starting material. We estimated this amp-
liﬁcation to be  5-fold in our case by spectrophotometrically
measuring the amount of cDNA subsequent to the labelling
reaction. This value seems reasonable since we can use as little
as 1 mg Klenow-labelled material (500 ng still work ﬁne) for
hybridization, whereas protocols using labelled aRNA or
RT-labelled cDNA require as much as 3–6 mg. Additionally,
Klenow fragment is known to have a superior efﬁciency with
modiﬁed nucleotides compared with any known RT.
Ourdatademonstratethattheabilitytoreproduciblyidentify
differentially expressed genes after ampliﬁcation is retained
Figure 4. Scatterplotscomparinglog2-transformedexpressionratiosofamplifiedtargetstoratiosobtainedwithunamplifiedtargets.BreastandreferenceRNAwas
used as starting material. Dye swap experiments were combined before plotting. Target amplified (TAcKLE) from (A) 2000 ng, (B) 200 ng, (C) 20 ng and (D)2n g
starting material was compared with unamplified target prepared by reverse transcription labelling. Orthogonal regression analysis was preformed to derive the
regression lines shown in red and their respective linear equations. Dashed lines through origin with slope 1 are displayed to accentuate the elevated slope. Pearson
correlation coefficients and their associated 95% confidence intervals are listed as well.
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This is true even when using as little starting material as 2 ng
total RNA. We detect some differences between transcription
proﬁles generated from 2000 and 2 ng of total RNA, probably
due to additional bias introduced by a second round of amp-
liﬁcation, which includes a randomly primed RT reaction. But
even after two rounds of ampliﬁcation, reproducibility is suf-
ﬁciently high for reliable quantiﬁcation of differences between
samples. Furthermore, and equally important, there is no com-
pression of differences between RNA samples with either one
or two rounds of ampliﬁcation. In contrast, there is a system-
atic and reproducible expansion of expression ratios in amp-
liﬁed targets. A possible explanation is differences in RT
efﬁciency, depending on the template concentration.
Our analyses also indicate that reverse transcription label-
ling represents a signiﬁcant source of variation between ident-
ical RNA samples and reafﬁrm the need for dye swap
replicates. A part of the deviating ratios detected when com-
paring ampliﬁed and unampliﬁed targets can probably be
attributed rather to the inaccuracy of reverse transcription
labelling than to systematic bias or random errors of the
ampliﬁcation procedure.
A different approach to overcome the problem of strand
orientation is the addition of ﬂuorescent nucleotide derivatives
to the in vitro transcription reaction. Barczak et al. (19)
reported decreased signal intensities of ﬂuorescent aRNA
targets, compared with cDNA prepared by reverse transcrip-
tion labelling. We could conﬁrm this effect (data not shown).
Figure5.Scatterplotsshowinglog2ratiosofthegenesdetectedasdifferentiallyexpressedbetweenbreastandreferenceRNAbyeitheroneorbothtargetpreparation
techniques(reversetranscriptionlabellingandamplificationviatheTAcKLEprotocol).DataareshownforthecomparisonsofRTlabellingversustargetsprepared
from(A)2000ng,(B)200ng,(C)20ngand(D)2ngstartingmaterial.Genesshowingdifferentialexpressionwithbothmethodsareshownasreddots,whileblueand
greendotsdenotegenesonlyfoundbyamplificationorRTlabelling,respectively.Thenumbersofgenesfoundup-ordown-regulatedwitheitheroneorbothmethods
are given in the lower right corners of the plots.
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the incorporation of dye-labelled nucleotides. As it clearly
discriminates bulky nucleotide modiﬁcations, ratios of
labelled to unlabelled nucleotides have to be optimized. It
has been reported that the addition of dimethyl sulfoxide dur-
ing in vitro transcription can improve incorporation rates (13),
and that utilization of aminoallyl-dUTP, followed by chemical
coupling of reactive dye derivatives, may overcome some of
the problems connected to the bulky nature of dye-labelled
nucleotides. Yet, there is no additional ampliﬁcation by the
labelling procedure. Another recent study (27) exploits the
template-switching effect (28) of MMLV RT to incorporate
an RNA polymerase promoter sequence upstream of the gen-
erated cDNA,producingsense-oriented RNAbysubsequent in
vitro transcription. In a similar approach, the method of ter-
minal continuation has been used to generate ampliﬁed tran-
scripts with either sense or antisense orientation (29).
Commercial solutions utilize novel signal ampliﬁcation
and/or detection procedures, as in the Qiagen HiLight Plat-
form (http://www1.qiagen.com/Products/MicroArrayAnaly-
sis/MicroArrayAnalysisSystems.aspx), which uses resonance
light scattering, a technology based on the optical light
scattering properties of nano-sized metal colloidal particles
(30). The system requires 1–2 mg total RNA and generates
biotinylated and/or ﬂuorescein-labelled target cDNA, which
can be hybridized to commercial or custom made arrays. Gold
particles, coated with anti-biotin antibodies, and/or silver par-
ticles, coated with anti-ﬂuorescein antibodies, are used to stain
the targets after hybridization. Detection is performed on a
specialized reader. The SensiChip System developed by Qia-
gen and Zeptosens AG (http://www.zeptosens.com) uses pla-
nar waveguide technology (31,32) and requires a minimum of
1 mg total RNA. Hybridizations are carried out on 70mer
oligonucleotide arrays of a special format using the SensiChip
Figure 6. Meandifference(MA)plotsdisplayingthedifferenceoflog2ratiosagainstthemeanoflog2ratios.Misameasureforthedifferenceoflog2ratiosobserved
between amplified and unamplified targets, prepared from breast and universal human reference RNA (log2 [breast/reference]TAcKLE   log2 [breast/reference]RT).
Aisameasurefortheaveragedifferentialexpression(1/2[log2[breast/reference]TAcKLE+log2[breast/reference]RT]).Ratiosoftargetsamplifiedfrom(A)2000ng,
(B) 200ng, (C) 20 ngand (D) 2 ngstartingmaterial werecomparedwithratiosofunamplifiedtargets.Replicated experiments wereaveragedbeforecalculatingthe
differencesandmeansoflog2 ratios.Blackdotscorrespondtoprobesdetectedonatleast onearrayofeachconsideredtargetpreparationapproach,probesshownas
reddotsadditionallyreachedfluorescenceintensitiesatleasttwostandarddeviationsabovelocalbackground.Therespectivequantitiesarespecifiedunderneaththe
panel headings, values for red dots given in parentheses. Values in the upper and lower left corners of each plot indicate genes that show at least a 2-fold change of
expression ratios to either direction, as illustrated by horizontal dashed lines.
e29 Nucleic Acids Research, 2005, Vol. 33, No. 3 PAGE 10 OF 12HybStation. Future studies will show whether comparable
results can be achieved with these alternative approaches.
In conclusion, we showed that TAcKLE can faithfully amp-
lify and label as little as 2 ng of total RNA, an amount which
canbe obtainedfrom afewhundred cells. Itrepresents a robust
method for the sensitive detection of expression proﬁles,
which is particularly suited for the use with microarrays
consisting of long sense-oriented oligonucleotides, which
are currently gaining popularity.
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